These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 36733547)
1. The Rationale for Using Corticosteroids in COVID-19 Encephalopathy: Lessons From a Case Report With Evidence From Literature. Ameer MA; Chaudhry H; Babar M; Patel N; Song M; Mathew M Cureus; 2023 Jan; 15(1):e33233. PubMed ID: 36733547 [TBL] [Abstract][Full Text] [Related]
2. COVID-19-associated encephalopathy: Neurological manifestation of COVID-19. Al Mazrouei SS; Saeed GA; Al Helali AA; Ahmed M Radiol Case Rep; 2020 Sep; 15(9):1646-1649. PubMed ID: 32690988 [TBL] [Abstract][Full Text] [Related]
3. Myoclonus status revealing COVID 19 infection. Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232 [TBL] [Abstract][Full Text] [Related]
4. Manifestation of Ocular Myasthenia Gravis as an Initial Symptom of Coronavirus Disease 2019: A Case Report. Rahimian N; Alibeik N; Pishgar E; Dini P; Abolmaali M; Mirzaasgari Z Iran J Med Sci; 2022 Jul; 47(4):385-388. PubMed ID: 35919075 [TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
7. Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke. Pensato U; Muccioli L; Pasini E; Tappatà M; Ferri L; Volpi L; Licchetta L; Battaglia S; Rossini G; Bon I; Re MC; Cirillo L; Simonetti L; Gramegna LL; Michelucci R; Cortelli P; Zini A; Bisulli F Front Neurol; 2020; 11():587226. PubMed ID: 33193051 [No Abstract] [Full Text] [Related]
8. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report. Gonzales-Zamora JA; Quiroz T; Vega AD Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623 [TBL] [Abstract][Full Text] [Related]
9. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
14. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293 [TBL] [Abstract][Full Text] [Related]
15. Posterior reversible encephalopathy syndrome - A pathology that should not be overlooked in the era of COVID-19. Ioan P; Ribigan AC; Rusu O; Bratu IF; Badea RS; Antochi F Am J Emerg Med; 2022 Jun; 56():393.e5-393.e8. PubMed ID: 35346531 [TBL] [Abstract][Full Text] [Related]
16. Neurological Sequelae of COVID-19. Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158 [TBL] [Abstract][Full Text] [Related]
17. Severe acute respiratory syndrome coronavirus 2-induced acute aortic occlusion: a case report. Minalyan A; Thelmo FL; Chan V; Tzarnas S; Ahmed F J Med Case Rep; 2021 Mar; 15(1):112. PubMed ID: 33653414 [TBL] [Abstract][Full Text] [Related]
18. A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report. Chen LD; Li H; Ye YM; Wu Z; Huang YP; Zhang WL; Lin L BMC Infect Dis; 2020 Jul; 20(1):517. PubMed ID: 32677909 [TBL] [Abstract][Full Text] [Related]
19. Case Report: Severe SARS-CoV-2 Infection Treated with Remdesivir in a Patient with ESRD. Patel RH; Pella PM; Haider N; Blanco R Infect Disord Drug Targets; 2022; 22(3):e011221198456. PubMed ID: 34852751 [TBL] [Abstract][Full Text] [Related]
20. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]